Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 12, Issue 20, pp. 6087-6093
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted August 3, 2006
- Received May 3, 2006
- Revision received July 20, 2006
- Published first October 24, 2006.
Copyright & Usage
American Association for Cancer Research
Author Information
- Grzegorz S. Nowakowski1,
- Andrea K. McCollum2,
- Matthew M. Ames1,2,
- Sumithra J. Mandrekar3,
- Joel M. Reid1,
- Alex A. Adjei1,
- David O. Toft4,
- Stephanie L. Safgren1 and
- Charles Erlichman1
- Authors' Affiliations:1Department of Oncology, 2Department of Molecular Pharmacology and Experimental Therapeutics, 3Cancer Center Statistics, and 4Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota
- Requests for reprints:
Charles Erlichman, Department of Oncology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905. Phone: 507-284-3514; Fax: 507-266-5146; E-mail: erlichman.charles{at}mayo.edu.
October 2006
Volume 12, Issue 20
Volume 12, Issue 20
A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer
Jump to section
Advertisement